Soy milk with a high glycitein content does not reduce low-density lipoprotein cholesterolemia in type II hypercholesterolemic patients

Annals of Nutrition and Metabolism

Volumn 46, Issue 2, 2002, Pages 88-92

  Sirtori, Cesare R ^a,b   Bosisio, Raffaella ^a   Pazzucconi, Franco ^a   Bondioli, Alighiero ^a   Gatti, E ^a   Lovati, Maria Rosa ^b   Murphy, Patricia ^c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Glycitein; Hypercholesterolemia; Isoflavones; Low density lipoprotein cholesterol; Soy milk; Soy protein

Indexed keywords

CHOLESTEROL; DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MILK; PRIORITY JOURNAL; PROTEIN DIET; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; ISOFLAVONES; MALE; MIDDLE AGED; SOYBEANS; TREATMENT OUTCOME;

EID: 0036253754     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057646     Document Type: Article

References (28)

1. Intake of 25 g soy protein reduces plasma cholesterol in men with elevated cholesterol concentrations
2. Reduction of serum cholesterol by soy proteins: Clinical experience and potential molecular mechanisms
3. Meta-analysis of the effects of soy protein intake on serum lipids
4. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic
5. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis or male cynomolgus monkeys
6. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women
7. Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolemia and resistance to or intolerance of statins
8. Isoflavones in retail and institutional soyfoods
9. Isoflavones in soy-based infant formulas
10. The analysis of the two-period repeated measurements crossover design with application to clinical trials
11. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells
12. Soybean protein products as regulators of liver low-density lipoprotein receptors. I. Identification of active β-conglycinin subunits
13. Soybean protein products as regulators of liver low-density lipoprotein receptors. II. α-α′-rich commercial soy concentrate and α′-deficient mutant differently affect low-density lipoprotein receptor activation
14. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients
15. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women
16. Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys
17. Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys
18. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: A randomized controlled trial in humans
19. Soly isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
20. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women
21. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profile of postmenopausal women with mild to moderate hypercholesterolemia
22. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
23. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women
24. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis
25. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity
26. Soy protein, with an without isoflavones and daidzein, lowers plasma cholesterol levels in golden Syrian hamsters
27. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men